This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Palmitic acid is a common 16-carbon saturated fat that represents 10-20% of human dietary fat intake and comprises approximately 25 and 65% of human total plasma lipids and saturated fatty acids, respectively. Acylation of palmitic acid to proteins facilitates anchoring of membrane-bound proteins to the lipid bilayer and trafficking of intracellular proteins, promotes protein-vesicle interactions, and regulates various G protein-coupled receptor functions. Palmitic acid (200 µM) increases NF-?B p65 levels, matrix metalloproteinase-9 (MMP-9) activity, and production of reactive oxygen species (ROS) in AsPC-1 pancreatic cancer cells, as well as increases migration of AsPC-1 cells. It increases COX-2 levels in RAW 264.7 cells and increases LPS-induced IL-1beta levels and caspase-1 activity in isolated mouse peritoneal macrophages. Dietary administration of palmitic acid (2.2% w/w for 12 weeks) increases mouse hippocampal beta-secretase 1 (BACE1) activity and amyloid beta (1-42) (Abeta42, Cay-20574) levels. It also induces systolic contractile dysfunction in isolated mouse hearts. Red blood cell palmitic acid levels are increased in patients with metabolic syndrome compared to patients without metabolic syndrome and are also increased in the plasma of patients with type 2 diabetes compared to individuals without diabetes.Formal Name: hexadecanoic acid. CAS Number: 57-10-3. Synonyms: C16:0, Cetylic Acid, FA 16:0, Hexadecanoic Acid, NSC 5030. Molecular Formula: C16H32O2. Formula Weight: 256.4. Purity: >98%. Formulation: (Request formulation change), A crystalline solid. Solubility: DMF: 20 mg/ml, DMSO: 20 mg/ml, Ethanol: 30 mg/ml, Ethanol:PBS (pH 7.2) (1:2): .25 mg/ml. SMILES: CCCCCCCCCCCCCCCC(O)=O. InChi Code: InChI=1S/C16H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h2-15H2,1H3,(H,17,18). InChi Key: IPCSVZSSVZVIGE-UHFFFAOYSA-N. Origin: Plant/Palm. Side Chain Carbon Sum: 16:0.
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the usability of this website, serve for direct advertising or simplify interaction with other websites and social networks, will only be used with your consent.
More information